{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:46:50Z","timestamp":1787107610981,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jaad.2023.05.017","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T06:47:06Z","timestamp":1684133226000},"page":"685-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination"],"prefix":"10.1016","volume":"89","author":[{"given":"Hyun Jeong","family":"Ju","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hee","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Hae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Min","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solam","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jaad.2023.05.017_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/pathogens11070743","article-title":"Analyzing the systems biology effects of COVID-19 mRNA vaccines to assess their safety and putative side effects","volume":"11","author":"Hajjo","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jaad.2023.05.017_bib2","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2023.05.017_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","article-title":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2023.05.017_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108721","article-title":"Covid-19 vaccine and autoimmunity: awakening the sleeping dragon","volume":"226","author":"Akinosoglou","year":"2021","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2023.05.017_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102741","article-title":"Autoimmune hepatitis after COVID-19 vaccine - more than a coincidence","volume":"125","author":"Garrido","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaad.2023.05.017_bib6","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","volume":"41","author":"Jara","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2023.05.017_bib7","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaad.2023.05.017_bib8","series-title":"Autoimmunity: from bench to bedside [internet]. Bogota (Colombia)","article-title":"Molecular mimicry in autoimmunity and vaccinations","author":"Blank","year":"2013"},{"key":"10.1016\/j.jaad.2023.05.017_bib9","first-page":"799","article-title":"Data resource profile: the national health information database of the national health insurance Service in South Korea","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jaad.2023.05.017_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","volume":"28","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2023.05.017_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40265-021-01480-7","article-title":"BNT162b2 mRNA COVID-19 vaccine: first approval","volume":"81","author":"Lamb","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2023.05.017_bib12","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2023.05.017_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jaad.2023.05.017_bib14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.jaad.2023.05.017_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108480","article-title":"Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases","volume":"217","author":"Vojdani","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaad.2023.05.017_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaad.2023.05.017_bib17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/ijd.16113","article-title":"Alopecia areata following COVID-19 vaccination: vaccine-induced autoimmunity?","volume":"61","author":"May Lee","year":"2022","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2023.05.017_bib18","doi-asserted-by":"crossref","first-page":"Np699","DOI":"10.1093\/asj\/sjac165","article-title":"Possible associations between alopecia areata and COVID-19 vaccination and infection","volume":"42","author":"Birkett","year":"2022","journal-title":"Aesthet Surg J"},{"key":"10.1016\/j.jaad.2023.05.017_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1089\/thy.2021.0142","article-title":"Two cases of Graves' disease following SARS-CoV-2 vaccination: an autoimmune\/inflammatory syndrome induced by adjuvants","volume":"31","author":"Vera-Lastra","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/j.jaad.2023.05.017_bib20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/annrheumdis-2021-220647","article-title":"Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study","volume":"80","author":"Furer","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.jaad.2023.05.017_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000525562","article-title":"ANCA-associated vasculitis following the first dose of pfizer-BioNTech COVID-19 vaccine","volume":"147","author":"El Hasbani","year":"2022","journal-title":"Nephron"},{"key":"10.1016\/j.jaad.2023.05.017_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ckj\/sfac026","article-title":"COVID-19 vaccination precipitating de novo ANCA-associated vasculitis: clinical implications","volume":"15","author":"Mai","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jaad.2023.05.017_bib23","article-title":"De-novo antineutrophil cytoplasmic antibody-associated vasculitis following the mRNA-1273 (Moderna) vaccine for COVID-19","volume":"13","author":"Feghali","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.jaad.2023.05.017_bib24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1016\/j.jaad.2023.05.017_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-246533","article-title":"Marked increase of interferon-\u03b2 after BNT162b2 mRNA vaccination: a case of polyarthritis with pleurisy","volume":"15","author":"Shimagami","year":"2022","journal-title":"BMJ Case Rep"},{"issue":"3","key":"10.1016\/j.jaad.2023.05.017_bib26","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2021.06.026","article-title":"Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination","volume":"148","author":"Tomayko","year":"2021","journal-title":"J Allergy Clin Immunol"}],"updated-by":[{"DOI":"10.1016\/j.jaad.2023.10.005","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223008290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962223008290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:28:48Z","timestamp":1759274928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962223008290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0190962223008290"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2023.05.017","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of autoimmune skin and connective tissue disorders after mRNA-based COVID-19 vaccination","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2023.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}